Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease
Janet T Scott,
Raman Sharma,
Luke W Meredith,
Jake Dunning,
Catrin E Moore,
Foday Sahr,
Steve Ward,
Ian Goodfellow,
Peter Horby,
RAPIDE-TKM trial team
Feb 19, 2020
BACKGROUND: TKM-130803 is a specific anti-EBOV therapeutic comprised of two small interfering RNAs (siRNA) siLpol-2 and siVP35-2. The pharmacokinetics (PK) of these siRNAs was defined in Ebola virus disease (EVD) patients, with...